RESULTS As GLP-1 stimulates insulin secretion and inhibits glucagon secretion in type 2 diabetes patients with residual -cell function, the use of GLP-1 has been proposed as a novel therapeutic option
Tirzepatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has demonstrated significant efficacy in clinical trials for weight loss
When you expose your gut to enteroendocrine cell inducers, the long-term response is increasing the number of those cells present, making you more able to release appetite-regulating hormones
The best peptide for visceral fat loss article provides detailed comparisons with other options in this category
Growth hormone, stimulated by sermorelin, improves insulin sensitivity through increased lean muscle mass and direct metabolic effects
The honest answer is nuanced